1 Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland.
2 Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland.
3 Molecular Modelling Group, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
4 Center of Experimental Therapeutics, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
5 Department of Medicine and Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland.
6 Division of Clinical Pathology, Department of Diagnostics, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
7 Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
8 Dana-Farber Cancer Institute, Boston, MA, USA.
9 Harvard Medical School, Boston, MA, USA.
10 Broad Institute of MIT and Harvard, Cambridge, MA, USA.
11 Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
12 Ludwig Institute for Cancer Research, Lausanne Branch, Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, Switzerland. alexandre.harari@chuv.ch.
13 Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, Switzerland. alexandre.harari@chuv.ch.